BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Altimmune Announces Positive Initial Data from Its HepTcell Phase I Study

  Altimmune today announced it has completed dosing of its HepTcell Phase 1 study in chronic hepatitis B.

  December 21, 2017

   · 

  4 min read
• Drug Development

  Basilea Reports That Ceftobiprole Received QIDP Designation From U.S. FDA for the Treatment of Staphylococcus Aureus Bacteremia (SAB)

  Basilea announced today that the U.S. FDA designated its investigational drug ceftobiprole as a QIDP.

  December 21, 2017

   · 

  5 min read
• 

  FDA

  FDA Grants De Novo Request for PROCEPT BioRobotics AQUABEAM System

  The AQUABEAM System, delivering Aquablation therapy, is the first FDA granted surgical robot providing autonomous tissue removal for the treatment of BPH.

  December 21, 2017

   · 

  4 min read
• Pharm Country

  Integral Molecular Expands Its Epitope Mapping Platform to Identify Small Molecule Binding Sites on Multipass Membrane Proteins

  Integral Molecular has now extended this mapping capability to small molecules, which comprise 50% of drugs in development.

  December 21, 2017

   · 

  2 min read
• 

  FDA

  CytoSorbents Gets FDA Greenlight For Pivotal Study of CytoSorb in Cardiac Surgery

  CytoSorbents announced that the FDA has granted approval of its REFRESH 2 IDE application.

  December 21, 2017

   · 

  6 min read
• Drug Development

  Longeveron Pioneering Development of Stem Cell Therapies for Aging Frailty

  The company is building on Phase 1 safety and Phase 2 safety, tolerability and efficacy studies conducted by the University of Miami Miller School of Medicine of Allogeneic MSCs in patients with aging frailty.

  December 21, 2017

   · 

  3 min read
• BioMidwest

  AIT Bioscience Presents at 14th Annual Indiana Life Sciences Summit

  On October 9th and 10th, AIT Bioscience employees had the opportunity to attend and present at the 14th Annual Indiana Life Sciences Summit in downtown Indianapolis.

  December 21, 2017

   · 

  1 min read
• Pharm Country

  200 Fine Chemicals Offered by Alfa Chemistry With 20% Discount for Christmas Promotion

  Alfa Chemistry, a global chemical company located in New York, offers an extensive catalog of research chemicals in a wide range of applications.

  December 21, 2017

   · 

  1 min read
• Genetown

  bluebird bio to Present at Investor Conferences in January

  Goldman Sachs 10th Annual Healthcare CEOs Unscripted, Thursday, January 4, at 3:15 p.m. ET at the InterContinental, Boston, Massachusetts.

  December 21, 2017

   · 

  3 min read
• Business

  vTv Therapeutics and Reneo Pharmaceuticals Enter Licensing Agreement for PPAR-Delta Program

  Under the terms of the agreement, vTv Therapeutics will receive an upfront payment and will be eligible to receive future development and commercialization milestones as well as royalties on sales of approved products. vTv Therapeutics will also receive shares of Reneo Pharmaceuticals’ common stock.

  December 21, 2017

   · 

  4 min read